These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18292714)

  • 1. Retapamulin (Altabax)--a new topical antibiotic.
    Med Lett Drugs Ther; 2008 Feb; 50(1280):13-5. PubMed ID: 18292714
    [No Abstract]   [Full Text] [Related]  

  • 2. Altabax (retapamulin ointment), 1%.
    Abramovits W; Gupta A; Gover M
    Skinmed; 2007; 6(5):239-40. PubMed ID: 17786102
    [No Abstract]   [Full Text] [Related]  

  • 3. Retapamulin: a review of its use in the management of impetigo and other uncomplicated superficial skin infections.
    Yang LP; Keam SJ
    Drugs; 2008; 68(6):855-73. PubMed ID: 18416589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiological profile of a new topical antibacterial: retapamulin ointment 1%.
    Scangarella-Oman NE; Shawar RM; Bouchillon S; Hoban D
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):269-79. PubMed ID: 19344241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retapamulin: a newer topical antibiotic.
    Dhingra D; Parakh A; Ramachandran S
    J Postgrad Med; 2013; 59(2):127-30. PubMed ID: 23793314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of retapamulin ointment as treatment of impetigo: randomized double-blind multicentre placebo-controlled trial.
    Koning S; van der Wouden JC; Chosidow O; Twynholm M; Singh KP; Scangarella N; Oranje AP
    Br J Dermatol; 2008 May; 158(5):1077-82. PubMed ID: 18341664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of retapamulin 1% ointment for the treatment of infected atopic dermatitis: a pilot study.
    Kircik LH
    J Drugs Dermatol; 2012 Jul; 11(7):858-60. PubMed ID: 22777229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retapamulin: a semisynthetic pleuromutilin compound for topical treatment of skin infections in adults and children.
    Jacobs MR
    Future Microbiol; 2007 Dec; 2(6):591-600. PubMed ID: 18041900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical retapamulin ointment, 1%, versus sodium fusidate ointment, 2%, for impetigo: a randomized, observer-blinded, noninferiority study.
    Oranje AP; Chosidow O; Sacchidanand S; Todd G; Singh K; Scangarella N; Shawar R; Twynholm M;
    Dermatology; 2007; 215(4):331-40. PubMed ID: 17911992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altabax approved to treat impetigo.
    Laustsen G
    Nurse Pract; 2007 Oct; 32(10):13. PubMed ID: 17901782
    [No Abstract]   [Full Text] [Related]  

  • 11. Topical retapamulin ointment (1%, wt/wt) twice daily for 5 days versus oral cephalexin twice daily for 10 days in the treatment of secondarily infected dermatitis: results of a randomized controlled trial.
    Parish LC; Jorizzo JL; Breton JJ; Hirman JW; Scangarella NE; Shawar RM; White SM;
    J Am Acad Dermatol; 2006 Dec; 55(6):1003-13. PubMed ID: 17097398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, comparative study to assess the safety and efficacy of topical retapamulin ointment 1% versus oral linezolid in the treatment of secondarily infected traumatic lesions and impetigo due to methicillin-resistant Staphylococcus aureus.
    Tanus T; Scangarella-Oman NE; Dalessandro M; Li G; Breton JJ; Tomayko JF
    Adv Skin Wound Care; 2014 Dec; 27(12):548-59. PubMed ID: 25396674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do Antimicrobial Resistance Patterns Matter? An Algorithm for the Treatment of Patients With Impetigo.
    Schachner LA; Andriessen A; Benjamin LT; Claro C; Eichenfield LF; Esposito SM; Keller L; Kircik L; Kwong PC; McCuaig C
    J Drugs Dermatol; 2021 Feb; 20(2):134-142. PubMed ID: 33538559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the surgical wound infection model to determine the efficacious dosing regimen of retapamulin, a novel topical antibiotic.
    Rittenhouse S; Singley C; Hoover J; Page R; Payne D
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3886-8. PubMed ID: 17065626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spotlight on retapamulin in impetigo and other uncomplicated superficial skin infections.
    Yang LP; Keam SJ
    Am J Clin Dermatol; 2008; 9(6):411-3. PubMed ID: 18973410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retapamulin for impetigo and other infections.
    Drug Ther Bull; 2008 Oct; 46(10):76-9. PubMed ID: 18832258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retapamulin: a new topical antibiotic for the treatment of uncomplicated skin infections.
    Parish LC; Parish JL
    Drugs Today (Barc); 2008 Feb; 44(2):91-102. PubMed ID: 18389088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy of ozenoxacin in animal models of dermal infection with Staphylococcus aureus.
    Tarragó C; Esquirol LP; Arañó A; Lachamp L; D'Aniello F; Zsolt I
    Future Microbiol; 2018 May; 13():21-30. PubMed ID: 29745240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ozenoxacin 1% cream (Xepi) for impetigo.
    Med Lett Drugs Ther; 2019 Apr; 61(1570):63-64. PubMed ID: 31169810
    [No Abstract]   [Full Text] [Related]  

  • 20. Ozenoxacin 1% cream in the treatment of impetigo: a multicenter, randomized, placebo- and retapamulin-controlled clinical trial.
    Gropper S; Albareda N; Chelius K; Kruger D; Mitha I; Vahed Y; Gani M; García-Alonso F;
    Future Microbiol; 2014; 9(9):1013-23. PubMed ID: 25340832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.